Evidence map›Paper›PMID 29273921›Full record

SynthesisJournal of gastrointestinal cancer2019

Is It Possible a Conservative Approach After Radiochemotherapy in Locally Advanced Rectal Cancer (LARC)? A Systematic Review of the Literature and Meta-analysis.

Francesco Fiorica, Marco Trovò, Gabriele Anania, Daniele Marcello, Fabrizio Di Benedetto, Marina Marzola, Fabrizio D'Acapito, Guglielmo Nasti, Massimiliano Berretta

Registry-linked trialOpen access · greenAbstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Journal of gastrointestinal cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07580027 (Preoperative, Adaptive Radiotherapy Concomitant to Chemotherapy for Rectal Adenocarcinoma), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07580027 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Preoperative, Adaptive Radiotherapy Concomitant to Chemotherapy for Rectal Adenocarcinoma (Adaptive Rectal Cancer Trial 02). An Interventional Study.

TypeinterventionalSponsorIRCCS San RaffaeleRan2026 to 2029Enrolled33ConditionsLocally Advanced Rectal CarcinomaArmsPreoperative, adaptive radiotherapy
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Organ Preservation in Rectal Cancer.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2020
    Review
  3. Treatment of Colorectal Cancer: a Multidisciplinary Approach.Journal of gastrointestinal cancer · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Francesco FioricaGastrointestinal Cancer Unit, Departments of Radiation Oncology, Medical Oncology and Surgery, University Hospital Ferrara, Ferrara, Italy. francesco.fiorica@unife.it.ORCID http://orcid.org/0000-0002-9404-3655
Marco TrovòDepartment of Radiation Oncology, Udine General Hospital, Udine, Italy.
Gabriele AnaniaGastrointestinal Cancer Unit, Departments of Radiation Oncology, Medical Oncology and Surgery, University Hospital Ferrara, Ferrara, Italy.
Daniele MarcelloGastrointestinal Cancer Unit, Departments of Radiation Oncology, Medical Oncology and Surgery, University Hospital Ferrara, Ferrara, Italy.
Fabrizio Di BenedettoDepartment of Liver and Multivisceral Transplant Center, Liver Surgery, University Hospital Modena, Modena, Italy.
Marina MarzolaGastrointestinal Cancer Unit, Departments of Radiation Oncology, Medical Oncology and Surgery, University Hospital Ferrara, Ferrara, Italy.
Fabrizio D'AcapitoDepartment of Surgery and Advanced Oncological Therapies, State Hospital Forlì, Forlì, Italy.
Guglielmo NastiDepartment of Abdominal Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione "G. Pascale"-IRCCS, Naples, Italy.
Massimiliano BerrettaDivision of Medical Oncology A, National Cancer Institute, IRCCS, Aviano, PN, Italy.
University of Ferrara · ITCentro di Riferimento Oncologico · ITIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · ITUniversity of Udine · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLocally advanced rectal cancer is usually treated with a preoperative approach with radiochemotherapy followed by surgery. Patients obtaining a pathologic complete response have a very favorable long-term prognosis. This study was intended to assess whether major surgery can reduce tumor recurrences and prolong survival of patients with a complete response after radiochemotherapy.

methodsComputerized literature search was performed to identify relevant articles. Comparative studies reporting the outcomes of non-operative and operative management in patients after neoadjuvant treatment were reviewed. Data synthesis was performed using Review Manager 5.0 software.

resultsTwelve non-randomized comparative studies with a total of 1812 patients were suitable for analysis. There was no significant difference in overall survival at 3 and 5 years (odds ratio [OR] 1.31; 95% CI 0.64-2.69; p = 0.46 and 1.48; 95% CI 1.00-2.20; p = 0.50) and in disease-free survival at 3 and 5 years (odds ratio [OR] 1.20; 95% CI 0.68-2.14; p = 0.53 and 1.22; 95% CI 0.86-1.74; p = 0.26, respectively) between locally advanced rectal cancer patients treated with and without operative approach.

conclusionsMajor surgery does not seem to improve prognosis in patients obtaining a complete response after radiochemotherapy. Clinical trials, using clear criteria to identify complete response patients, are needed to recommend non-operative approach.

Indexed as

ChemoradiotherapyFemaleHumansMaleRectal NeoplasmsSurvival RateConservative approachRadiochemotherapyRectal cancer conservative approach

Identifiers

PMID29273921
OpenAlexW2777006353

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.